Filing Flows › Comparisons › XBIO vs PRTA
Xenetic Biosciences vs Prothena Corp Public: XBIO and PRTA compared
Xenetic Biosciences is the larger company: $661K of revenue in its latest quarter (Q2 2026) against $620K for Prothena Corp Public (Q3 2026). Xenetic Biosciences is growing faster (+12% against -74% a year earlier).
Where the money goes: XBIO and PRTA
Xenetic Biosciences (XBIO) · Q2 2026
Xenetic Biosciences, Q2 2026: revenue $661K (+12% year over year), operating margin -147.1%, net loss $930K, operating cash flow −$875K. The chart follows the revenue to costs, profit and cash.
Prothena Corp Public (PRTA) · Q3 2026
Prothena Corp Public, Q3 2026: revenue $620K (-74% year over year), net loss $16.5M, operating cash flow −$12.0M. The chart follows the revenue to costs, profit and cash.
| Xenetic Biosciences (XBIO) | Prothena Corp Public (PRTA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $661K | $620K |
| Revenue growth, Y/Y | +12% | -74% |
| Operating margin | -147.1% | n/m |
| Net earnings | −$930K | −$16.5M |
| Net margin | -140.7% | — |
| Operating cash flow | −$875K | −$12.0M |
Questions
Which is bigger, Xenetic Biosciences or Prothena Corp Public?
Xenetic Biosciences is the larger company: $661K of revenue in its latest quarter (Q2 2026) against $620K for Prothena Corp Public (Q3 2026).
Is Xenetic Biosciences or Prothena Corp Public growing faster?
Xenetic Biosciences is growing faster (+12% against -74% a year earlier).
More: Xenetic Biosciences earnings · how Xenetic Biosciences makes money · Prothena Corp Public earnings · how Prothena Corp Public makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.